This site is intended for Healthcare Professionals only.

Tag: MHRA

spot_imgspot_img

Abott issues voluntary recall for Alimentum and EleCare powder formula

American health care company, Abott has voluntarily recalled powder formulas of Alimentum and EleCare after consumer complaints of bacterial contamination, the Pharmaceutical Services Negotiating...

Class 4 medicines defect information issued for Flamingo Pharma’s Ibuprofen 400mg tablets

The Medicines and Healthcare products Regulatory Agency has issued a class 4 medicines defect information for Flamingo Pharma's Ibuprofen 400mg Tablets, EL (22)A/04. The medicine...

Lung cancer patients to benefit from ground-breaking new drug on NHS

Thousands of lung cancer patients in England will benefit from a ground-breaking new drug that can reduce the risk of relapse. This follows a deal brokered...

MHRA extends licence for treatment for cystic fibrosis – Kaftrio

Hundreds of children in England are set to benefit from a treatment for cystic fibrosis – Kaftrio, after the UK’s Medicines and Healthcare products...

MHRA approves second oral Covid-19 antiviral, Paxlovid

UK regulator has approved a second oral antiviral for early treatment of Covid-19 in high-risk adults, after molnupiravir called Paxlovid. The Medicines and Healthcare products Regulatory...

UK regulator approves new formulation of Pfizer-BioNTech Covid-19 vaccine for under 12s

UK regulator has approved a new age-appropriate formulation of the Pfizer BioNTech Covid-19 vaccine for use in children aged 5 to 11 years old. The...